![Debra Yu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 179 584 $ in data 30/06/2026
Debra Yu is currently Independent Director at MeiraGTx Holdings Plc since 2022, Independent Non-Executive Director at JW (Cayman) Therapeutics Co. Ltd. since 2023, Independent Non-Executive Director at Ascentage Pharma Group International Co., Ltd. since 2024, Advisor at JDRF International, Treasurer at Institute for Advanced Study, and General Manager at Shanghai Lianbio Development Co., Ltd. Former roles include Independent Director at ARYA Sciences Acquisition Corp.
V, Senior Director at Pfizer Venture Investments LLC from 2004 to 2008, Managing Director at Bay City Capital LLC, Director at Permanente Co., Director at The BayHelix Group from 2018 to 2020, Managing Director at Labrador Advisors LLC from 2009 to 2016, MD & Head-Cross Border Healthcare Investment at China Renaissance Securities (US), Inc. from 2016 to 2019, Consultant at McKinsey & Co., Inc. from 1992 to 1994, Principal at Wilkerson Group, Principal at Morgan Stanley Venture Partners, General Partner at Delphi Ventures, Inc. from 1995 to 1999, Senior Vice President-Global Business Development at Ascendancy Healthcare, Inc., Vice President-Strategy at WUXI APPTEC, INC from 2008 to 2009, and President & Chief Strategy Officer at LianBio from 2021 to 2023.
Education includes an undergraduate degree from Princeton University conferred in 1986 and a doctorate from Harvard Medical School conferred in 1992.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
LIANBIO 0,95% | 10/04/2023 | 1.000.000 ( 0,95% ) | 135 250 $ | 30/06/2026 |
| 20/04/2026 | 10.472 ( 0% ) | 44 334 $ | 30/06/2026 | |
| 11/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MEIRAGTX HOLDINGS PLC | Direttore/Membro del Consiglio | 25/04/2022 |
| JW (CAYMAN) THERAPEUTICS CO. LTD | Direttore/Membro del Consiglio | 01/03/2023 |
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Direttore/Membro del Consiglio | 25/11/2024 |
Shanghai Lianbio Development Co., Ltd.
 Shanghai Lianbio Development Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures paradigm-shifting medicines to patients | Amministratore Delegato | - |
Institute for Advanced Study, Inc.
 Institute for Advanced Study, Inc. Miscellaneous Commercial ServicesCommercial Services Provides theoretical research and intellectual inquiry services | Treasurer | - |
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services Performs research & development on diabetes | Corporate Officer/Principal | - |
| Società | Posizione | Fine |
|---|---|---|
| LIANMEDICAL | Presidente | 01/01/2023 |
The BayHelix Group
 The BayHelix Group Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit professional organization | Direttore/Membro del Consiglio | 01/01/2020 |
China Renaissance Securities (US), Inc.
 China Renaissance Securities (US), Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/09/2019 |
| ░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 22 |
|---|---|
China Renaissance Securities (US), Inc.
China Renaissance Securities (US), Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Wilkerson Group
 Wilkerson Group Medical/Nursing ServicesHealth Services Consulting services to pharmaceutical and medical products industry | Health Services |
Morgan Stanley Venture Partners
 Morgan Stanley Venture Partners Investment ManagersFinance MVSP invests in companies located in the United States. The firm targets companies operating in the fields of technology, healthcare, consumer and digital media. It participates in growth stage capital requirements. | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Venture Investments LLC
 Pfizer Venture Investments LLC Investment ManagersFinance Pfizer Ventures Investments invests in companies located across the globe primarily in the United States. The firm focuses on companies operating in oncology, inflammation & immunology, cardiovascular, metabolic/Obesity and Vaccines sectors. It provides financing for seed, early and growth stage capital requirements with an investment size of USD 5 - 20 million. The firm make follow on financing and also acts as lead investor. | Finance |
Delphi Ventures, Inc.
 Delphi Ventures, Inc. Investment ManagersFinance Delphi Ventures invests in companies located in the United States. The firm targets companies operating in the fields of medical devices & diagnostics, biotechnology and healthcare services companies. It provides financing for early stage capital requirements. | Finance |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital invests in public and private companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital transactions. The firm makes co-investments. It acts as a lead investor and takes a seat on the board of directors. | Finance |
JDRF International
JDRF International Miscellaneous Commercial ServicesCommercial Services Performs research & development on diabetes | Commercial Services |
Institute for Advanced Study, Inc.
Institute for Advanced Study, Inc. Miscellaneous Commercial ServicesCommercial Services Provides theoretical research and intellectual inquiry services | Commercial Services |
Permanente Co.
 Permanente Co. Real Estate DevelopmentFinance Part of Kaiser Permanente Corp., Permanente Co. is a multispecialty medical group consisting of over 9,500 physicians who provide world-class medical care to 4.6 million Kaiser Permanent members in the US. The company offers flexible practice opportunities in Family Medicine and Internal Medicine, with in-person and/or virtual care and dedicated panel management time. The group is physician-led and focuses on the health, wellness, and happiness of their people as much as their patients. The company is regarded as experts in their field and are regularly featured in the media on a variety of health issues. The CEO of the company is John H. Cochran. | Finance |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The BayHelix Group
The BayHelix Group Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit professional organization | Commercial Services |
Ascendancy Healthcare, Inc.
 Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Engages in the commercialization of pharmaceutical products | Health Technology |
Wuxi Apptec, Inc.
 Wuxi Apptec, Inc. Data Processing ServicesTechnology Services Provides pharmaceutical and biotechnology services | Technology Services |
Ascentage Pharma Group International Co., Ltd.
 Ascentage Pharma Group International Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering, developing and commercializing of therapies for hematological malignancies | Health Technology |
MeiraGTx Holdings Plc
 MeiraGTx Holdings Plc BiotechnologyHealth Technology Develops and manufactures genetic medicines | Health Technology |
JW (Cayman) Therapeutics Co. Ltd.
 JW (Cayman) Therapeutics Co. Ltd. BiotechnologyHealth Technology Operates as biotechnology company that develops and manufactures cell immunotherapy products | Health Technology |
LianBio
 LianBio BiotechnologyHealth Technology Operates as a biotechnology company focused on bringing paradigm-shifting medicines to patients | Health Technology |
ARYA Sciences Acquisition Corp. V
 ARYA Sciences Acquisition Corp. V Financial ConglomeratesFinance Operates as a blank check company | Finance |
Shanghai Lianbio Development Co., Ltd.
Shanghai Lianbio Development Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures paradigm-shifting medicines to patients | Health Technology |
Labrador Advisors LLC |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
